Modern prostate cancer diagnosis and treatment

Written by: Mr Marc Laniado
Published: | Updated: 20/12/2018
Edited by: Nicholas Howley

We’ve become much more advanced in how we test for prostate cancer and make a decision on the right treatment to give. In this article we asked consultant urologist Mr Marc Laniado what patients can expect from the process and what your results mean.

How do doctors assess my risk of prostate cancer?

The main way is to have a blood test known as PSA. Your doctor may or may not combine it with an examination of the prostate using a finger inserted into the back passage.

PSA is a triage test – depending on the level, either no or more investigations are necessary. For example, if your PSA is high, you should confirm it is still high on a second PSA test a few weeks later, as often the first PSA result can be a false reading, and the PSA value can return to normal after a while.

To avoid false positives, you need to avoid exercise, ejaculation, or prostate stimulation for two days before, and the PSA should not be measured if a urinary tract infection is present.

What happens if my PSA results are high?

If you have two high PSA results or the prostate feels like it may have a cancer, then ideally you should have a multiparametric MRI performed on a high-quality MRI scanner and interpreted by radiologists with specific training.

If the mpMRI shows that significant prostate cancer is likely, a doctor should take a biopsy targeted to the abnormality seen on the MRI.

What happens if prostate cancer is found?

If prostate cancer is found, then the treatment plan needs to be personalised. That means either:

  • active surveillance for slow-growing cancer, which is contained within the prostate.
  • treating just part of the prostate with cancer - known as focal therapy or partial ablation
  • surgical techniques with a high chance of success and fewer side effects than standard surgery, such as Retzius-sparing prostatectomy with NeuroSAFE, techniques involving radiotherapy such as brachytherapy, or some other advanced forms of radiotherapy.

Are there any alternatives to the PSA test?

Recently, a urine test called SelectMDx has become available in the UK, which appears to perform better than PSA. However, not so much is known about this test or how it fits into the current pathway to diagnose prostate cancer.

Occasionally, the SelectMDx test may have a help decide to have a prostate biopsy where other tests are unhelpful.

By Mr Marc Laniado

Mr Marc Laniado is dedicated to returning men to as normal a life as possible when suffering from prostate enlargement or with prostate cancer. He is a highly experienced urologist and works full time in the direct clinical care of men with prostate problems. As the prostate cancer and multidisciplinary urological cancer lead, he has developed and delivers minimally invasive techniques daily that have significantly helped his patients. He provides individually-tailored therapies alleviating urinary symptoms or reducing the chance of dying from prostate cancer, with the greatest chance of preserving erections, ejaculation and bladder control.

Mr Marc Laniado graduated from Guy's Hospital Medical School in 1989, having previously gained a BSc in physiology. Following specialist urology training in London, he became a Fellow of the Royal College of Surgeons (Urology) in 2000, going on to complete his MD in prostate cancer research, Fellow of the European Board of Urology in 2002 and international member of the American Urological Association. Prior to taking up his career as a consultant, Mr Laniado extended his knowledge and skills on a Visiting Fellowship at the Cleveland Clinic Foundation in the USA, where he trained in minimally invasive surgical techniques. 

Mr Laniado was appointed as a consultant to Wexham Park Hospital (Frimley Health) in 2002, where he is the lead for prostate cancer. specialising in rapid diagnostic techniques and minimally invasive treatments for prostatic enlargement and prostate cancer. He is the prostate cancer lead clinician and urological cancer multidisciplinary lead. His private practice is based in Harley Street, London, and in Windsor, Berkshire

View Profile

Overall assessment of their patients

We use cookies on this site to enhance your user experience. Click ‘Enter’ to continue browsing. Enter Cookies policy